Abstract
Hydroxyapatite is one of the most widely used materials in biomedical applications in reparative and regenerative medicine. Doping of nanosized hydroxyapatite improves its bioactive properties, and thus, the synthesis of different types of nanohydroxyapatite with antimicrobial activity is a perspective route of modern materials science. In this study, undoped hydroxyapatite (HAp), hydroxyapatite doped with silver (HAp with 0.1, 0.5 and 1 mol% Ag+ ions), and silicate-substituted hydroxyapatite doped with silver (Si-HAp with 0.1, 0.5 and 1 mol% Ag+ ions) nanoparticles (NPs) were synthesized by microwave-assisted hydrothermal technique and sintered at 450 °C. The structural properties and composition of obtained hydroxyapatite NPs were investigated using X-ray powder diffraction (XRPD), Fourier-transformed infrared spectroscopy (FT-IR), and Energy-dispersive X-ray spectroscopy (EDS). The morphology of synthesized nanosized powders was detected using the high-resolution transmission electron microscopy (HRTEM) technique. The results of XRPD for all synthesized nanosized powders confirmed the presence of hydroxyapatite crystal structure. The FT-IR spectra confirmed the presence of functional groups characteristic of the hydroxyapatite structure. The EDS analysis of obtained materials has shown the presence of Ca, P, O, Si, and Ag elements. Significant differences in size and morphology of the obtained particles were found using HRTEM. The particles have an elongated, rod-like shape with subtle differences. Moreover, HAp doped with 1 mol% Ag+ ions and Si-HAp doped with 1 mol% Ag+ ions nanosized powders showed antibacterial activity in comparison to pure hydroxyapatite both against gram-positive and gram-negative bacterial strains (Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus epidermidis, Staphylococcus aureus, Enterococcus faecalis). These two types of hydroxyapatite NPs also demonstrated antifungal activity against reference strains of Candida albicans, Candida kruzei, and Candida tropicalis, with stronger activity observed for Si-HAp doped with silver.
Keywords: Hydroxyapatite compounds, Silver, Silicate, Antibacterial properties, Antifungal properties
Subject terms: Infection, Biomaterials
Introduction
Minerals within the apatite group demonstrate widespread occurrence in natural environments and biological specimens1. The hydroxyapatite (HAp), with the formula Ca10(PO4)6(OH)2, is the primary inorganic component of vertebrate bones and teeth. Le Geros described bone mineral as a carbonate-hydroxyapatite, with the chemical formula (Ca, X)10(PO4, HPO4, CO3)6(OH, Y)2, where Xn+ represents cations that can replace calcium ions (Mg2+, Na+, Sr2+), and Y− represents anions that can substitute for the hydroxyl group (Cl− or F−)1. Gross and Berndt further reported that in addition to these elements, natural apatite (found in bone, enamel, and dentine) contains trace amounts of various ions, including K+, Ba2+, Pb2+, Fe3+, Zn2+, Cu2+, Al3+, Si4+, Mn2+, Se2+, Sn2+, K+, Li+, Ni2+, Ag+ are present in trace quantities within natural apatite (found in bone, enamel, and dentine)2. Synthetic high-aspect-ratio nanostructured HAp is attractive for a wide range of applications such as replacement bone tissue, drug delivery systems, catalysis, and environmental, and can interact with biological systems, such as cells and proteins, in unique ways3.
In this study, we focus on incorporating silicon and silver ions in synthetic HAp due to their distinctive and potentially beneficial properties. Silicon plays an important role in bone and cartilage systems4. Incorporating 0.8 and 1.5 wt% of orthosilicate groups into hydroxyapatite has been shown to significantly increase the rate of bone apposition to HAp bioceramic implants after 6 and 12 weeks. The mechanism by which silicate ions increase in vivo bioactivity has been explained, highlighting the enhanced potential of these ceramics for biomedical applications5. Authors of other work6 demonstrated the effect of silicon-substituted HAp on the differentiation of human osteoblasts and their ability to induce mineralization compared to pure HAp. Silicate anions (SiO44−) can structurally be included in the HAp lattice instead of phosphate ions. This substitution affects the crystal lattice parameters of silicon-substituted HAp and depends on the content of silicon groups, the synthesis method, and the subsequent heat-treatment temperature. Authors of other studies7,8 have shown that (PO4)3− groups could be substituted for (SiO4)4− in the silicon-substituted HAp without forming other crystalline phases. Substitution of phosphate group by silicate in the apatite structure increases the lattice parameters in both a-axis and c-axis of the unit cell9. Silicon-substituted HAp can be prepared by high-temperature solid-state reaction using Ca2P2O7, CaCO3, and SiO210 by hydrothermal method using tetraethylorthosilicate Si(OCH2CH3)4 (TEOS) solution11 or tetramethylammonium silicate (CH3)4N(OH)·2H2O (TMAS)12, by precipitation method13–15 and others. However, when using silicon acetate (Si(CH3COO)4 in a precipitation method together with high sintering temperature it can lead to the formation of biphasic or multiphase calcium phosphate ceramic16. By using microwave heating, Si-HAp nanocrystals could be nucleated rapidly with high efficiency compared to other methods17. Additionally, a microwave-assisted hydrothermal method can contribute to producing silicate-substituted HAp nanoparticles (HAp NPs) doped with various ions18. It can be rare-earth ions, for example, Eu3+ ions19,20, which have good luminescent properties. In this case, the doping ion’s choice depends on the synthesized material’s purpose.
It is well established that any medical procedure or intervention in the human body carries a risk of infections. Therefore, the use of antibiotics is an integral part of the treatment protocol for medical interventions. Due to the increased drug resistance among microorganisms observed in recent years, it is crucial to search for novel strategies to prevent and treat microbial infections. Doping hydroxyapatites with various ions can change their properties, for instance Sr enhance HAp solubility and Mg increase its fracture toughness. For antibacterial activity Zn2+ and Ag+ dopants have been chosen most frequently, with the greater growth inhibition observed for Ag-doped HAp21). The antibacterial properties of silver are well-known. Moreover, the development of multi-resistant bacteria, as in the case of antibiotics, is less likely22. This effect is caused mainly by silver ions, which have a wide antibacterial spectrum, and also by silver nanoparticles (Ag NPs)22. In addition, some studies show the presence of a synergistic effect of some antibiotics and silver23. Hydroxyapatite doped with silver has been synthesized using methods such as sol-gel24,25, precipitation26–29, hydrothermal synthesis30, and microwave-assisted techniques31. It had indicated that incorporating silver ions into HAp could contribute viably to excellent antibacterial activities against P. aeruginosa to prevent bone infection32. It is crucial to select the optimal concentration of silver for doping hydroxyapatite to minimize silver toxicity. The cell adhesion assays showed that osteoblast cell attachment in varying density was noticed on HAp samples doped with 0.5, 1 and 1.5 mol% Ag+ ions. However, osteoblast function was significantly greater on HAp 0.5 mol% Ag+ compound now than on 1 and 1.5 mol% Ag+ ions samples, and osteoblast cells were attached but could not spread as HAp doped with 0.5 mol% Ag+ ions suggesting that HAp compounds with a low amount of silver are more favorable for implant applications31. It is important to highlight the varied cellular responses and cytotoxic effects induced by AgNPs and HAp NPs. Previous studies33have described the initial cellular response to AgNP exposure, suggesting mechanisms such as apoptosis or necrosis, particularly at concentrations of 50 µg mL⁻¹, which also resulted in decreased cell adhesion. In contrast, HAp NPs showed a potential for recovery in cell proliferation, even at higher concentrations, indicating a more biocompatible interaction with cells. HAp doped with silver ions demonstrates a clear antimicrobial effect26–29,32, including applications in theranostics27. Considering that the silicate group in apatite improves its bioactive properties and silver ions have an antibacterial effect, combining these substitutions in one material would be interesting and promising. Our previous work demonstrated antifungal Ag-doped Si-HAp NPs synthesized via the hydrothermal method and sintered at 600 ºC in which three phosphate groups ((PO4)3−) were replaced with three silicate groups ((SiO4)4−)30. It is crucial to investigate whether reducing the amount of dopant and lowering the sintering temperature can preserve the antimicrobial and antifungal properties of doped hydroxyapatite, and how these modifications compare to undoped hydroxyapatite.
The present study aims to prepare silver-doped hydroxyapatite and silver-doped silicate-substituted hydroxyapatite nanoparticles and characterize them in comparison to undoped hydroxyapatite nanoparticles, including X-ray powder diffraction, energy dispersive X-ray spectroscopy, Fourier-transform infrared spectroscopy, and high-resolution transmission electron microscopy, as well as its antibacterial and antifungal properties. Such nanoparticles could be used as medical materials, enhancing biocompatibility and reducing the risk of microbial infections during implantation procedures.
Materials and methods
Synthesis of the undoped hydroxyapatite, silver-doped hydroxyapatite, and silver-doped silicate-substituted hydroxyapatite NPs
Synthesis of the undoped hydroxyapatite NPs (HAp NPs)
As substrates, the following were used: Ca(NO3)2·4H2O (99.0–103.0%, Alfa Aesar, Haverhill, MA, USA), (NH4)2HPO4 (> 99.0%, Acros Organics, Schwerte, Germany). To obtain stoichiometric hydroxyapatite, the concentrations of reagents were selected according to the required Ca/P molar ratio of 1.67. Stoichiometric amounts of substrates were dissolved separately in deionization water. All starting substrates were mixed into a Teflon vessel. The ammonia solution (NH3·H2O, 25%, Avantor, Poland) was used to obtain a pH level of around 9–10. The hydrothermal synthesis was conducted in a microwave reactor (ERTEC MV 02–02, Wrocław, Poland) for 90 min at 220–250 °С and under autogenous pressure (42–45 bar)20. The obtained material was dried at the temperature of 80 °С and then heat-treated at the temperature of 450 °C for 3 h (3 °C/min).
Synthesis of the silver-doped hydroxyapatite NPs (Ag-doped HAp NPs)
The synthesis of silver-doped hydroxyapatite was carried out as described above in paragraph 2.1.1. The source of silver ions was AgNO3 (99.9% Avantor Performance Materials Poland S.A, Gliwice, Poland). The chosen concentrations of silver were 0.1, 0.5, and 1 mol% in a ratio of calcium ion molar content. Obtained NPs were named HAp: 0.1 mol% Ag+, HAp: 0.5 mol% Ag+, and HAp: 1 mol%Ag+.
Synthesis of the silver-doped silicate-substituted hydroxyapatite NPs (Ag-doped Si-HAp NPs)
The synthesis of silver-doped silicate-substituted hydroxyapatite was carried out as described above in paragraph 2.1.1. The source of silver ions was AgNO3 (99.9% Avantor Performance Materials Poland S.A, Gliwice, Poland). The chosen concentrations of silver were 0.1, 0.5, and 1 mol% in a ratio of calcium ion molar content. The source of one silicate group was tetraethyl orthosilicate TEOS (> 99%, Alfa Aesar, Haverhill, MA, USA). Obtained NPs were named Si-HAp: 0.1 mol% Ag+, Si-HAp: 0.5 mol% Ag+ and Si-HAp: 1 mol% Ag+ .
Characterization
X-ray powder diffraction (XRPD)
PANalytical X’Pert Pro X-ray diffractometer (Malvern Panalytical Ltd., Malvern, UK) with a Cu–K radiation at 2θ range from 10̣º to 80º (exposure time of 1,5 h) was applied to determine structure and crystallinity of obtained materials. The diffraction patterns were juxtaposed with standards from the Inorganic Crystal Structure Database (hydroxyapatite ICSD-151941 and silicate-substituted hydroxyapatite ICSD-32357).
The phase purity, average crystallite size and cell parameters were calculated by the Rietveld method. The structural refinement was performed using the Maud program version 2.55, based on the hexagonal apatite crystal structure with improved approximation and indexing of the Crystallographic Information File (CIF). The Levenberg–Marquardt algorithm was applied along with the pseudo-Voigt approximation. The quality of the structural refinement was evaluated using Rw-values.
Energy dispersive X-ray spectroscopy (EDS)
The chemical composition was checked by an FEI Nova NanoSEM 230 scanning electron microscope equipped with an energy-dispersive spectrometer (EDAX Genesis XM4). The EDS analysis has shown the existence of Ca, P, O, Si, and Ag elements in the obtained materials. The EDS spectra were recorded in triplicate for each sample, and the reported values represent the mean of these measurements.
Fourier transform infrared (FT-IR) spectroscopy
By FT-IR spectroscopy, the characteristic molecular vibrations were revealed. Spectra were collected by a Thermo Scientific Nicolet iS50 FT-IR spectrometer equipped with an Automated Beamsplitter exchange system (iS50 ABX containing DLaTGS KBr detector), built-in all-reflective diamond ATR module (iS50 ATR), Thermo Scientific Polaris™. The HeNe laser was used as an infrared radiation source. The FT-IR spectra were recorded using the ATR module, in the range of mid-infrared radiation.
High-resolution transmission electron microscopy
The morphology of the samples was determined by high-resolution transmission electron microscopy (HRTEM), using a Philips CM-20 SuperTwin instrument operating at 160 kV. Specimens were prepared by dispersing the sample in methanol and putting a droplet of the suspension on a microscope copper grid covered with carbon. Samples were then dried and purified in oxygen/hydrogen plasma in a plasma cleaner. Statistical analysis of TEM measurements data were done by grain size distribution curve.
Antimicrobial activity of nanoapatites
Antibacterial and antifungal activity of silver-doped nanosized apatite compounds were tested on the following bacterial: Staphylococcus aureus ATCC 6538, Staphylococcus epidermidis ATCC 12,228, Enterococcus faecalis ATCC 51,299, Klebsiella pneumoniae subsp. pneumoniae ATCC 700,603, Pseudomonas aeruginosa ATCC 27,853 and fungal: Candida albicans ATCC 90,028, Candida kruzei ATCC 2159 and Candida tropicalis ATCC 750 strains. Colloidal solutions of nanosized apatite materials were prepared as described before30. Briefly, 10 mg/ml of HAp, HAp: 1 mol%Ag+ and Si-HAp: 1 mol%Ag+ in minimal medium (SD - Synthetic Defined for antifungal testing: Yeast Nitrogen Base 6.7 g/l, Glucose 20 g/l; Minimal Davies for antibacterial testing, ammonium sulfate 1 g/l, monopotassium phosphate 2 g/l, dipotassium phosphate 7 g/l, sodium citrate 0.5 g/l, magnesium sulfate 0.1 g/l, glucose 1 g/l) was sonicated and diluted 10x in an appropriate medium. Antibacterial activity was tested in a 96-well flat-bottom microtiter plate. Bacterial overnight cultures in LB medium (Luria Broth, Bioshop) were centrifuged and suspended in minimal medium to obtain optical density of 0.5 McF and diluted 10x in minimal medium. The wells were filled with 10 µl of bacterial solution, 10 µl of HAp, and 80 µl of the medium. Plates were incubated for 18 h at 37 ± 0.5 °C without shaking, and optical density was measured at 600 nm using a microplate reader (VarioSkan LUX, Thermo Fisher Scientific). Antifungal activity was measured in SD medium as described before30.
Results and discussion
X-ray powder diffraction analysis
The XRPD patterns of synthesized hydroxyapatite NPs have been shown in Fig. 1. It is known that hydroxyapatite crystallizes in hexagonal P63/m space group with lattice constants an equal to 0.942 and c equal to 0.688 nm34. Obtained XRPD patterns of undoped HAp, HAp doped with silver, and Si-HAp doped with silver were compared with the X-ray pattern of hexagonal hydroxyapatite (ICSD-15194110), and silicate-substituted hydroxyapatite (ICSD-3235735), from the ICSD (Inorganic Crystal Structure Database), respectively. After sintering at 450 °С, the crystalline phase of hydroxyapatite was obtained in the samples of all compositions, but there are some differences between pure hydroxyapatite and both silver-doped HAp and silver-doped silicate-substituted HAp.
Fig. 1.
XRPD patterns of undoped HAp, HAp, and Si-HAp NPs doped with 0.1, 0.5, and 1.0 mol% Ag+ ions synthesized under hydrothermal conditions (at 240 °C and under 42–45 bar) and sintered at 450 °C.
Early in work27 was established in the case of nanosized HAp doped with 1–2 mol% Ag+ ions (synthesized by precipitation method and sintered at 450 ºC), the sample HAp doped with 1 mol% Ag+ ions was monophasic, but the sample doped with 2 mol% Ag+ ions contained an additional phase of Ag0 (ICSD-2243436). It was also established that heat-treating of nanosized HAp doped only 0.5 mol% Ag+ ions (synthesized by microwave process) higher than 700 ºC leads to the presence of the additional phase of Ag0 31. Synthes HAp doped with mol% Ag+ ions via ultrasonic coupled sol-gel techniques with next heat treatment at 600 ºC also leads to the formation of secondary phases, including tricalcium phosphate phase (β-TCP)37. Now, in this work, the analysis of X-ray patterns of HAp doping is 0.1, 0.5, and 1 mol% Ag+ ions synthesized using a hydrothermal method with a microwave reactor that showed the presence of a small peak of metallic silver (ICSD-2243436) at about 2θ equal to ~ 38º for HAp doped with 0.5 and 1 mol% Ag+ ions, and this peak is more noticeable with increasing content of silver. Moreover, silicate substituted HAp doped with 0.1, 0.5 and 1 mol% Ag+ ions, the peak of silver, is not just as noticeable. This is most likely due to some changes in the crystal lattice when replacing phosphate ions with silicone ions in the hydroxyapatite structure, as was established earlier12, and this contributes to better incorporation of doped ions into the hydroxyapatite structure20.
The formation of α- or β-TCP phases during the sintering of hydroxyapatite could be observed in both cases: when the phosphate group is replaced by silicate group13 and when calcium ions are replaced by silver ions in the hydroxyapatite structure31. For instance, the α-TCP formation was observed with replacement higher than one phosphate group (1.25) in silicon-substituted hydroxyapatite synthesized by a precipitation route and heat-treated at 1000 °C13. Also, early β-TCP formation was observed in HAp doped with Ag+ ions ≥ 1.5 at. mol% synthesized by microwave process and heat-treated at 900 °C31. Thus, two types of substitution (anionic and cationic) and their combination, as well as the use of hydrothermal synthesis that promoted the preparation of nanosized powders, could contribute to the β-TCP formation. In general, the presence of a small amount of the β-TCP phase in the prepared materials is a positive point, as it is known to have not only osteoconductive but also osteoinductive effects38. In this work XRPD patterns of Si-HAp: 1% Ag+ andHAp: 1% Ag+, aswell as HAp: 0.5 mol% Ag+ demonstrated the presence of some small additional peaks that showed secondary phase formation identified as β-TCP (ICSD-97500). It is mostly related to the higher concentration of silver (1 mol%) in these samples (see Table 1). The formation of the hexagonal phase and the successful substitution of silver and silicate ions were confirmed. Figure 2 shows a good match between the observed XRPD pattern and the theoretical fit. Minimal differences in intensity, as represented by the line (YObs − YCalc), demonstrate the success of the Rietveld refinement. Further details regarding the Rietveld analysis are provided in Table 1.
Table 1.
Unit cell parameters (a, c), crystal cell volume (V), grain size (nm), as well as a refined factor (Rw) for the HAp and β-TCP.
| Cell parameters | Phase | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| HAp | β-TCP | HAp (%) | β-TCP (%) | grain size [nm] | Rw (%) | |||||
| Sample | a (Å) | c (Å) | V (Å3) | a (Å) | c (Å) | V (Å3) | ||||
| s. c. | 9.424(4) | 6.879(4) | 529.09(54) | 10.4352(2) | 37.4029(5) | 3527.26(14) | – | – | – | – |
| HAp | 9.429(3) | 6.886(4) | 530.25(13) | – | – | – | 100 | – | 66.2(2) | 4.0(4) |
| HAp: 0.1 mol% Ag+ | 9.430(9) | 6.886(1) | 530.40(82) | – | – | – | 100 | – | 56.2(1) | 3.9(3) |
| HAp: 0.5 mol% Ag+ | 9.430(1) | 6.886(4) | 530.34(13) | 10.4358(6) | 37.4013(0) | 3527.55(52) | 99.6 | 0.4 | 93.4(1) | 4.6(3) |
| HAp: 1 mol% Ag+ | 9.432(2) | 6.887(0) | 530.62(38) | 10.4393(0) | 37.4023(9) | 3529.98(40) | 97.7 | 2.3 | 95.2(1) | 4.5(1) |
| Si-HAp: 0.1 mol% Ag+ | 9.427(5) | 6.889(3) | 530.27(21) | – | – | – | 100 | – | 47.7(2) | 2.5(3) |
| Si-HAp: 0.5 mol% Ag+ | 9.429(1) | 6.886(8) | 530.25(97) | – | – | – | 100 | – | 70.2(4) | 2.9(1) |
| Si-HAp: 1 mol% Ag+ | 9.437(1) | 6.891(0) | 531.48(38) | 10.4696(4) | 38.0694(5) | 3613.85(51) | 94.8 | 5.2 | 43.4(2) | 4.8(2) |
s. c. – single crystal reference data, HAp – ICSD-26,204, β-TCP – ICSD-97,50039.
Fig. 2.
Representative Rietveld analysis results of the nanosized 0.1 mol% Si-HAp: Ag+, sintered at 450 °C, (black – experimental result; red – fitted diffraction; green – differential pattern, violet column – reference phase peak position).
The cell parameters as well as grain average size were calculated. The results are collected in Table 1. When comparing the cell volume of undoped HAp with other materials after the addition of silver, we can see that these values are similar, but the highest one is seen for the Si-HAp: 1 mol% Ag. The average grain size is smaller for the silicate-substituted HAp with the same concentration of silver ions.
Elemental analysis
The EDX spectra confirmed the presence of all elements (calcium, phosphorus, silver, silicon, and oxygen) in the prepared samples. Figure 3 shows the results of EDX analysis for undoped HAp, HAp doped with silver, and Si-HAp doped with silver (with the maximum amount of silver dopant − 1 mol%). Based on EDS analysis (Fig. 3, b, c), the concentrations of silver ions in HAp: 1 mol% Ag and Si-HAp: 1 mol% Ag samples are 0.97 mol% and 1.18 mol%, respectively, corresponding with the assumed value (1%). Regarding Si (Fig. 3, c), the content of this element equals 3.16 mol% (or 0.19 mol concerning the total mol number (6) of Si and P).
Fig. 3.
EDX analysis of undoped HAp, HAp: 1 mol% Ag+ and Si-HAp: 1 mol% Ag+, synthesized under hydrothermal conditions (at 240 °C and under 42–45 bar) and sintered at 450 °C.
It is known that the molar ratio of Ca/P in stoichiometric hydroxyapatite with the formula Ca10(PO4)6(OH)2 is 1.67. However, the biological hydroxyapatite is non-stoichiometric due to the presence of other ions and functional groups40, and in the human body, the molar ratio also depends on the gender, age, and health condition of a patient. In the case of synthetic hydroxyapatite, the molar ratio of Ca/P depends on the method and parameters of synthesis and other conditions. In this work, the obtained value for pure HAp was 1.68 and practically corresponded to stoichiometric HAp. In the case of HAp doped with silver, the molar ratio (Ca + Ag)/P slightly deviated from such for pure HAp and was 1.75, and for silicate-substituted hydroxyapatite, the molar ratio (Ca + Ag)/(P + Si) was 1.57. The analogical molar ratio (Ca)/(P + Si) also was obtained in work12, where this ratio was 1.58 for sample Si-HAp with 0.36 (SiO4)4− group (where the sum of (SiO4)4− and (PO4)3− equals 6) synthesized hydrothermal method. This correlates with our results since we obtained Ag+: Si-HAp, which also included less than one silicate group (Fig. 3).
FT-IR analysis
Figure 4 shows FT-IR spectra of undoped HAp, HAp: 1 mol% Ag+, and Si-HAp: 1 mol% Ag+, sintered at 450 °C. Spectrum of undoped HAp shows bands corresponding to the vibrational modes of phosphate and hydroxide groups, characteristic of HAp13. The bands at 1100, 1034, and 962 cm− 1 (P-O stretching vibrations) and the doublet at 602 and 562 cm− 1 (O-P-O bending vibrations) originate from phosphate groups17. OH− groups can be identified by the bands corresponding to stretching vibrations at 3572 cm− 1 and bending vibrations at 631 cm− 1 17. The same bands are present in the spectra of the samples HAp: 1 mol% Ag+ and Si-HAp: 1 mol% Ag+ 17,20, with no significant difference in the shapes and intensity of the peaks compared to the spectra of undoped HAp.
Fig. 4.
FT-IR spectra of undoped HAp, HAp: 1 mol% Ag+ and Si-HAp: 1 mol% Ag+, synthesized under hydrothermal conditions (at 240 °C and under 42–45 bar) and sintered at 450 °C.
The visible broad band in the 1400–1600 cm− 1 region originates from carbonate ions (CO32−). The maximum is visible at 1415 cm− 1 (ν₃, asymmetric stretching vibrations). This band is present in all spectra (undoped HAp, HAp: 1 mol% Ag+, and Si-HAp: 1 mol% Ag+). The presence of carbonates is due to “B-type” carbonate substitution when carbonate ions substitute for phosphate41. The reason behind the spontaneous carbonation is the adsorption of CO2 from the air during the synthesis and calcination. Additionally, the band detected at 875 cm− 1 originates from the bending vibrations of the carbonate group (δCO32−), also related to intrinsic carbonation42, as well as it is overlaid with the vibrational modes from Si-O20. This band may also correspond to the stretching vibrations of hydrogen phosphate ions (νsHPO42−), which could result from calcium deficiency linked to the first charge compensation mechanism. However, as the band assigned to the carbonates is also detected in the 1400–1600 cm− 1 region, the hydrogen phosphate origin is a secondary consideration.
Some decrease of 631 cm− 1 and 3572 cm− 1 modes for the OH− group due to the presence of the (SiO4)4− group, which coincides with the data for silicate-substituted apatite17. According to the authors43, these changes in the hydroxyl stretching bands at 3570 and 630 cm− 1 are the most notable effects of ionic substitution on comparing the IR spectra of the pure and Si-substituted hydroxyapatite because the substitution of silicon into the hydroxyapatite framework reduces the amount of hydroxyl group to compensate for the extra negative charge of the silicate group and confirmed (PO4)3− tetrahedra replacement by (SiO4)4− tetrahedra in the hydroxyapatite structure.
High-resolution transmission Electron Microscopy
The study of the morphology of undoped and doped HAp NPs is of great importance, as the shape and size of the particles can significantly influence their properties. Figure 5 shows TEM images and the particle size distribution of undoped HAp, HAp: 1 mol% Ag+, and Si-HAp: 1 mol% Ag+ nanosized particles sintered at 450 °C. Moreover, the grain size distribution curve has been presented in Fig. 5.
Fig. 5.
TEM images and particle size distribution of undoped HAp NPs, HAp: 1 mol% Ag+ NPs, and Si-HAp: 1 mol% Ag+ NPs synthesized under hydrothermal conditions (at 240 °С and under 42–45 bar) and sintered at 450 °C.
From the TEM images, it can be seen that the crystals of undoped HAp NPs synthesized under microwave hydrothermal conditions have an elongated rounded shape, namely nanorods, and wide size distribution. The HAp particle size is in the wide range of 20–260 nm in length and 10–160 nm in width. The analysis of particle size distribution showed the presence of the main fraction 40–60 nm for length and width with the maximum peak in the range 20–40 nm. Generally, the average particle size in length is 96 nm, and in width is 48 nm.
Nanocrystals of HAp: 1 mol% Ag+ have a more elongated shape than pure HAp crystals and narrower particle length distribution. Particle size distribution is in the range of 20–300 nm in length with a maximum peak in the range of 80–100 nm and 20–120 nm in width with a maximum peak of 20–40 nm. Thus, adding silver to HAp leads to the formation of longer particles with an average length size of 130 nm but thinner ones with an average width size of 43 nm.
Particles of Si-HAp: 1 mol% Ag+ have an even more elongated shape than undoped HAp and HAp: 1 mol% Ag+ particles, which are intermediate between rods and needles. Replacing a group (PO4)3− with a group (SiO4)4− in the sample HAp: 1 mol% Ag+ contributes to a significant decrease in particle in length (average size of 124 nm) and in width (average size of 32 nm). Particle size distribution is in the range of 25–275 nm in length (a maximum peak is in the range of 80–100 nm) and 10–70 nm in width (a maximum peak is in the range of 25–50 nm). A high-resolution lattice image of Si-HAp: 1 mol% Ag+ NPs is presented in Fig. 6.
Fig. 6.
High-resolution lattice image of Si-HAp: 1 mol% Ag+ NPs synthesized under hydrothermal conditions (at 240 °С and under 42–45 bar) and sintered at 450 °C.
In general, for both undoped and doped HAp NPs, the width particle size maximum peaks in the 25–50 nm range, while for the length particle size, the peak is 50–75 nm for undoped HAp and shifts to larger sizes for doped HAp. Ag-HAp NPs made by modified sol–gel technique was shown to have elongated rod-like morphology with the length of the nanorods varying from 110 to 180 nm and the diameter varying between 20 and 25 nm25.
Thus, it has been established that doping with silver and dual doping with silver and (SiO4)4−-group significantly affect the morphology of hydroxyapatite nanocrystals, which can subsequently affect the properties of prepared materials, including antibacterial and antifungal activities. HAp NPs doped with bioactive ions and synthesized by microwave-assisted hydrothermal technique exhibited a change in morphology in previous studies44. The size of Ce-substituted HAp NPs increased with the Ce3+ concentration, while in the case of Mg-substituted HAp NPs, a change in the morphology was observed as the Mg2+ concentration increased, acquiring a platelet shape at 5% substitution44.
Antimicrobial activity of nanosized apatite compounds
Antibacterial activity
Antibacterial effects of nanoapatites against gram-positive (S. aureus, S. epidermidis and E. faecalis) and gram-negative strains (K. pneumoniae and P. aeruginosa) are shown in Fig. 7. The growth of all tested strains was significantly inhibited at the concentration of 0.1 mg/ml of Ag+-HAp and Ag+-Si-HAp (p < 0.05). The antibacterial activity of silver in all its forms is well documented. Silver ions have multiple effects on bacterial cells, interacting with major enzymes and disrupting plasma membranes, among others45. As hydroxyapatites are applied as medical materials, developing novel structures to increase their biological properties is important. HAps doped with silver ions were shown to have antimicrobial potential against gram-positive and gram-negative bacteria. For instance, Ag-doped HAp developed by Ciobanu et al. was active against S. aureus and K. pneumoniae46. Ivankovic et al. showed that Ag+ ions substituted hydroxyapatite exhibited antimicrobial activity against Acinetobacter baumanii compared to pure HAp47. We compared the antibacterial activity of silver-doped HAp modified and unmodified with silica. It was shown that silica-substituted Ag+-HAp has a slightly better antibacterial effect against S. epidermidis and E. faecalis. However, the activity against the remaining strains was similar (Fig. 7). We did not observe any significant difference in the antibacterial activity of Ag+-doped HAps against gram-positive and gram-negative strains, consistent with some published data. Ciobanu et al. showed similar inhibitory effects of Ag+: HAp NPs against S. aureus and K. pneumonia On the other hand, HAp modified with silver nanosized particles exhibited much stronger antibacterial activity against gram-negative strains than gram-positive ones48. Gram-positive bacteria possess thick cell walls that may prevent nanoparticles from penetratingthe plasma membrane45. Since one the main medical applications of nanoapatite is bone replacement, implanted material should be modified in a way to reduce the risk of post-surgical infection. Osteomyelitis is one of the most common complications of orthopedic surgery, with S. aureus, S. epidermidis and P. aeruginosa as most frequent etiological agents49. Silica-substituted Ag+-HAps developed by our team show strong activity against these microbes, thus they are promising orthopedic materials that inhibit the risk of infection.
Fig. 7.
The inhibition of bacterial growth by the control group, undoped HAp, HAp: 1 mol% Ag+ and Si-HAp: 1 mol% Ag+ NPs against reference strains Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus epidermidius, Staphylococcus aureus, and Enterococcus faecalis: mean ± SD, n = 3, *- statistically significant (p < 0.05).
Antifungal activity
Antifungal activity of silver-doped nanoapatites was tested against three reference Candida sp. strains: C. albicans, C. kruzei and C. tropicalis, and the results are shown in Fig. 8. These chosen species are among the most common human pathogens and are associated with candidiasis50. Previously tested HAp substituted with 3 silica groups showed strong antifungal effects against multiple yeast-like strains30. Here, we compare the inhibitory effect of Ag+-doped HAp modified with silicate group and un-modified silver-doped HAp. We showed the stronger antifungal effect of silica-substitution, especially in the case of C. albicans, in which growth was inhibited almost completely. The difference in the inhibition of C. tropicalis and C. kruzei growth was lower but still statistically significant (p < 0.05). Silver, especially in the form of nanoparticles, may have multiple effects on fungal cells, including oxidative stress and membrane disruption that would lead to cell death51. Antifungal properties of hydroxyapatite are desired due to its application in dental implantation. Candida sp. present in oral cavity are common agents of implant infections as they can adhere to its surface and form biofilms52 Increasing resistance to antibiotics among Candida sp. generates the necessity of developing alternative methods to combat fungal infections53. Implant materials with incorporated antifungal ions are a good candidates to prevent the infection.
Fig. 8.
The inhibition of Candida albicans, Candida kruzei and Candida tropicalis growth by the control group, the undoped HAp, HAp: 1 mol% Ag+ and Si-HAp: 1 mol% Ag+ NPs, mean ± SD, n = 3. *- statistically significant (p < 0.05).
Conclusions
This study elucidated the significant role of cationic and anionic doping in nanocrystalline hydroxyapatite with bioactive additives such as Ag+ ions and (SiO4)4− groups. It was demonstrated that minimal silver doping (1 mol% of calcium) and anionic doping with less than one silicate group significantly influenced the antifungal properties of the synthesized materials. Utilizing a microwave-assisted hydrothermal technique followed by low-temperature sintering (450 ºC), we successfully obtained the crystalline phase of hydroxyapatite across all types and compositions of doped HAp nanosized particles.
Our findings revealed that silver and dual doping with silver and silicate groups substantially affect the morphology of hydroxyapatite nanocrystals. Undoped HAp nanocrystals exhibited an elongated rounded shape with a wide size distribution. Doping with 1 mol% Ag+ ions resulted in the formation of longer, more elongated particles with a narrower length distribution. Dual doping (Si-HAp: 1 mol% Ag+) further enhanced this effect, producing nanorods. Both HAp: Ag+ and Si-HAp: Ag+ demonstrated significant antibacterial activity against gram-positive and gram-negative bacteria, irrespective of the presence of the silicate group. However, regarding antifungal effect, the silicate groups enhanced the activity with it. High antimicrobial properties of studied hydroxyapatites make them promising medical materials that decrease a threat of an infection.
This study highlights that the antibacterial properties of doped hydroxyapatite are primarily attributable to silver ions, while the silicate group’s contribution (in synergy with silver ions) is most evident in antifungal activity. Given the wide-ranging medical applications of hydroxyapatite and the growing challenge of drug resistance among microorganisms, developing novel biologically active materials like those explored in this research is crucial for overcoming infections.
Acknowledgements
The authors would like to acknowledge M.Sc. E. Bukowska for the XRD measurements and Dr. Damian Szymanski for the EDS measurements. The authors would like to acknowledge the National Science Centre Poland (NCN) for financial support within the Projects ‘Biocompatible materials with theranostics’ properties for precision medical application’ (No. UMO-2021/43/B/ST5/02960) under the National Science Centre Poland (NCN) and ‘Nanosized composites with biomimetics’ properties for precise medical application’ (BPN/BEK/2023/1/00309, Bekker programme) under the Polish National Agency for Academic Exchange. Nataliia D. Pinchuk would like to acknowledge the program supporting Ukrainian scientists organized by the Polish Academy of Science (PAS).
Author contributions
P.N.D. – methodology, investigation, writing-original draft, writing - review & editing, visualization, formal analysis, data curation, project administration; P.A. – methodology, investigation, writing-original draft, writing - review & editing, visualization, formal analysis, data curation; C.N. - methodology, investigation, formal analysis, visualization, reviewing-editing; S.P. - methodology, investigation, writing - review & editing, visualization, project administration; T.S. – methodology, investigation, reviewing-editing; B.O. – methodology, investigation; O.R. –review & editing, resources; W.Y. - – review & editing; W.R.J. - conceptualization, resources, funding acquisition, review & editing.
Data availability
The datasets analysed during the current study are available from the corresponding author on reasonable request.
Declarations
Competing interests
The authors declare no competing interests.
Footnotes
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Contributor Information
Paulina Sobierajska, Email: p.sobierajska@intibs.pl.
Rafal J. Wiglusz, Email: rafal.wiglusz@polsl.pl, Email: r.wiglusz@intibs.pl, Email: rjw283@cornell.edu
References
- 1.Le Geros, R. Z. Properties of Osteoconductive Biomaterials: Calcium Phosphates. Clin. Orthop. Relat. Res.395, 81–98 (2002). [DOI] [PubMed] [Google Scholar]
- 2.Gross, K. A. & Berndt, C. C. Biomedical Application of apatites. Rev. Mineral. Geochem.48, 631–672 (2002). [Google Scholar]
- 3.Diez-Escudero, A., Espanol, M. & Ginebra, M. P. High-aspect-ratio nanostructured hydroxyapatite: towards new functionalities for a classical material. Chem. Sci.15, 55–76 (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Henstock, J. R., Canham, L. T., Anderson, S. I. & Silicon The evolution of its use in biomaterials. Acta Biomater.11, 17–26 (2015). [DOI] [PubMed] [Google Scholar]
- 5.Porter, A. E., Patel, N., Skepper, J. N., Best, S. M. & Bonfield, W. Comparison of in vivo dissolution processes in hydroxyapatite and silicon-substituted hydroxyapatite bioceramics. Biomaterials24, 4609–4620 (2003). [DOI] [PubMed] [Google Scholar]
- 6.Botelho, C. M. et al. Human osteoblast response to silicon-substituted hydroxyapatite. doi: (2006). 10.1002/jbm.a.30806 [DOI] [PubMed]
- 7.Botelho, C. M., Lopes, M. A., Gibson, I. R., Best, S. M. & Santos, J. D. Structural analysis of Si-substituted hydroxyapatite: zeta potential and X-ray photoelectron spectroscopy. J. Mater. Sci. Mater. Med.13, 1123–1127 (2002). [DOI] [PubMed] [Google Scholar]
- 8.El Yacoubi, A., Massit, A., Fathi, M., Idrissi, E., Yamni, K. & B. C. & Characterization of silicon-substituted hydroxyapatite powders synthesized by a wet precipitation method. IOSR J. Appl. Chem.7, 24–29 (2014). [Google Scholar]
- 9.Dhouib, B. et al. The effect of pH and the process of direct or inverse synthesis of silicon-substituted hydroxyapatite prepared by hydrolysis in aqueous medium. Journal: J. Adv. Chem.9, 2033–2045 (2014). [Google Scholar]
- 10.Arcos, D., Rodríguez-Carvajal, J. & Vallet-Regí, M. The effect of the silicon incorporation on the hydroxylapatite structure. A neutron diffraction study. Solid State Sci.6, 987–994 (2004). [Google Scholar]
- 11.Tang, X. L., Xiao, X. F. & Liu, R. F. Structural characterization of silicon-substituted hydroxyapatite synthesized by a hydrothermal method. Mater. Lett.59, 3841–3846 (2005). [Google Scholar]
- 12.Moreno-Perez, B. et al. Synthesis of silicon-substituted hydroxyapatite using hydrothermal process. Boletín De La. Sociedad Española De Cerámica Y Vidrio. 59, 50–64 (2020). [Google Scholar]
- 13.Marchat, D. et al. Accurate characterization of pure silicon-substituted hydroxyapatite powders synthesized by a new precipitation route. Acta Biomater.9, 6992–7004 (2013). [DOI] [PubMed] [Google Scholar]
- 14.Bianco, A., Cacciotti, I., Lombardi, M. & Montanaro, L. Si-substituted hydroxyapatite nanopowders: synthesis, thermal stability and sinterability. Mater. Res. Bull.44, 345–354 (2009). [Google Scholar]
- 15.Harden, F. J., Gibson, I. R. & Skakle, J. M. S. Simplification of the synthesis method for Silicon-substituted hydroxyapatite: a Raman Spectroscopy Study. Key Eng. Mater.529–530, 94–99 (2012). [Google Scholar]
- 16.Gomes, S., Nedelec, J. M., Jallot, E., Sheptyakov, D. & Renaudin, G. Silicon Location in Silicate-substituted calcium phosphate ceramics determined by Neutron Diffraction. Cryst. Growth Des.11, 4017–4026 (2011). [Google Scholar]
- 17.Padmanabhan, S. K., Ul Haq, E. & Licciulli, A. Rapid synthesis and characterization of silicon substituted nano hydroxyapatite using microwave irradiation. Curr. Appl. Phys.14, 87–92 (2014). [Google Scholar]
- 18.Targonska, S., Szyszka, K., Rewak-Soroczynska, J. & Wiglusz, R. J. A new approach to spectroscopic and structural studies of the nano-sized silicate-substituted hydroxyapatite doped with Eu3+ ions. Dalton Trans.48, 8303–8316 (2019). [DOI] [PubMed] [Google Scholar]
- 19.Targonska, S. & Wiglusz, R. J. Studies of Luminescence Properties of Eu3+Ions Doped the Silicate-Substituted Apatite and Co-Doped with Strontium Ions. NATO Sci. Peace Secur. Ser. B: Phys. Biophys.10.1007/978-94-024-2138-5_45 (2022). [Google Scholar]
- 20.Targonska, S. & Wiglusz, R. J. Investigation of Physicochemical Properties of the Structurally Modified Nanosized Silicate-Substituted Hydroxyapatite Co-Doped with Eu 3 + and Sr 2 + ions. Nanomaterials11, 27 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Uskoković, V. Ion-doped hydroxyapatite: An impasse or the road to follow? Ceram. Int.46, 11443–11465 (2020). [Google Scholar]
- 22.Nakamura, S. et al. Synthesis and Application of Silver Nanoparticles (Ag NPs) for the Prevention of Infection in Healthcare Workers. Int. J. Mol. Sci.20, 3620 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Abo-Shama, U. H. et al. Synergistic and Antagonistic Effects of Metal Nanoparticles in Combination with Antibiotics Against Some Reference Strains of Pathogenic Microorganisms. Infect. Drug Resist.13, 351–362 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Deshmukh, K. R., Ramanan, S. R. & Kowshik, M. Low-temperature-processed biocompatible Ag-HAp nanoparticles with anti-biofilm efficacy for tissue engineering applications. J. Solgel Sci. Technol.80, 738–747 (2016). [Google Scholar]
- 25.Jadalannagari, S., Deshmukh, K., Ramanan, S. R. & Kowshik, M. Antimicrobial activity of hemocompatible silver doped hydroxyapatite nanoparticles synthesized by modified sol–gel technique. Appl. Nanosci.4, 133–141 (2014). [Google Scholar]
- 26.KIM, T. N. et al. Antimicrobial effects of metal ions (Ag+, Cu2+, Zn2+) in hydroxyapatite. J. Mater. Sci. Mater. Med.9, 129–134 (1998). [DOI] [PubMed] [Google Scholar]
- 27.Paluch, E. et al. Nanoapatites Doped and Co-Doped with Noble Metal Ions as Modern Antibiofilm Materials for Biomedical Applications against Drug-Resistant Clinical Strains of Enterococcus faecalis VRE and Staphylococcus aureus MRSA. Int. J. Mol. Sci.23, 1533 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Weiss, K. M., Kucko, S. K., Mokhtari, S., Keenan, T. J. & Wren, A. W. Investigating the structure, solubility, and antibacterial properties of silver- and copper‐doped hydroxyapatite. J. Biomed. Mater. Res. B Appl. Biomater.111, 295–313 (2023). [DOI] [PubMed] [Google Scholar]
- 29.Gokcekaya, O. et al. Effect of Precursor Deficiency Induced Ca/P Ratio on Antibacterial and Osteoblast Adhesion Properties of Ag-Incorporated Hydroxyapatite: Reducing Ag Toxicity. Materials14, 3158 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Piecuch, A., Targońska, S., Rewak-Sorczyńska, J., Ogórek, R. & Wiglusz, R. J. New silicate-substituted hydroxyapatite materials doped with silver ions as potential antifungal agents. BMC Microbiol.23, 193 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Rameshbabu, N. et al. Antibacterial nanosized silver substituted hydroxyapatite: Synthesis and characterization. J. Biomed. Mater. Res. A. 80A, 581–591 (2007). [DOI] [PubMed] [Google Scholar]
- 32.Zhao, Y. et al. Silver-substituted hydroxyapatite inhibits Pseudomonas aeruginosa outer membrane protein F: A potential antibacterial mechanism. Biomaterials Adv.134, 112713 (2022). [DOI] [PubMed] [Google Scholar]
- 33.Veschi, E. et al. Validation of Electrical Impedance Technique in Real-Time Using the xCELLigence as an Interference-Free Method for Assessing Cytotoxicity of Silver and Hydroxyapatite Nanoparticles. J. Braz Chem. Soc.10.21577/0103-5053.20240151 (2024). [Google Scholar]
- 34.Narasaraju, T. S. B. & Phebe, D. E. Some physico-chemical aspects of hydroxylapatite. J. Mater. Sci.31, 1–21 (1996). [Google Scholar]
- 35.Yacoubi, A., El, Idrissi, A., Rezzouk, A. & Idrissi, B. C. El. Structural Effects of Silicon Substitution on Hydroxyapatite Structure with High Substitution Ratio By Rietveld’s Analysis. Chem. J.1, 325–332 (2018). [Google Scholar]
- 36.Swathi, S., Arun, K., Dzubinska, A., Reiffers, M. & Nagalakshmi, R. Systematic investigations on the magnetic properties of moderate heavy Fermion CeAg0.68Si1.32 alloy. Phys. B Condens. Matter. 575, 411679 (2019). [Google Scholar]
- 37.Kamonwannasit, S. et al. Synthesis of copper-silver doped hydroxyapatite via ultrasonic coupled sol-gel techniques: structural and antibacterial studies. J. Solgel Sci. Technol.96, 452–463 (2020). [Google Scholar]
- 38.Bohner, M. & Santoni, B. L. G. Döbelin, N. β-tricalcium phosphate for bone substitution: Synthesis and properties. Acta Biomater.113, 23–41 (2020). [DOI] [PubMed] [Google Scholar]
- 39.Sudarsanan, K. & Young, R. A. Significant precision in crystal structural details. Holly Springs hydroxyapatite. Acta Crystallogr. B. 25, 1534–1543 (1969). [Google Scholar]
- 40.Driessens, F. C. M. Probable phase composition of the mineral in bone. Z. für Naturforschung C. 36, 357–362 (1980). [DOI] [PubMed] [Google Scholar]
- 41.Astala, R. & Stott, M. J. First Principles Investigation of Mineral Component of Bone: CO 3 Substitutions in Hydroxyapatite. Chem. Mater.17, 4125–4133 (2005). [Google Scholar]
- 42.Sima, L. E. et al. Differentiation of mesenchymal stem cells onto highly adherent radio frequency-sputtered carbonated hydroxylapatite thin films. J. Biomed. Mater. Res. A. 95A, 1203–1214 (2010). [DOI] [PubMed] [Google Scholar]
- 43.Kim, S. R. et al. Synthesis of Si, Mg substituted hydroxyapatites and their sintering behaviors. Biomaterials24, 1389–1398 (2003). [DOI] [PubMed] [Google Scholar]
- 44.Burdusel, A. C. et al. Microwave-Assisted Hydrothermal Treatment of Multifunctional Substituted Hydroxyapatite with Prospective Applications in Bone Regeneration. J. Funct. Biomater.14, 378 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Jung, W. K. et al. Antibacterial Activity and Mechanism of Action of the Silver Ion in Staphylococcus aureus and Escherichia coli. Appl. Environ. Microbiol.74, 2171–2178 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Ciobanu, C. S., Iconaru, S. L., Le Coustumer, P., Constantin, L. V. & Predoi, D. Antibacterial activity of silver-doped hydroxyapatite nanoparticles against gram-positive and gram-negative bacteria. Nanoscale Res. Lett.7, 324 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Ivankovic, T. et al. Antibacterial activity of silver doped hydroxyapatite toward multidrug-resistant clinical isolates of Acinetobacter baumannii. J. Hazard. Mater.458, 131867 (2023). [DOI] [PubMed] [Google Scholar]
- 48.Silva-Holguín, P. N. & Reyes-López, S. Y. Synthesis of Hydroxyapatite-Ag Composite as Antimicrobial Agent. Dose-Response18, 155932582095134 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Ribeiro, M., Monteiro, F. J. & Ferraz, M. P. Infection of orthopedic implants with emphasis on bacterial adhesion process and techniques used in studying bacterial-material interactions. Biomatter2, 176–194 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Turner, S. A. & Butler, G. The Candida Pathogenic Species Complex. Cold Spring Harb Perspect. Med.4, a019778–a019778 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Jian, Y. et al. Toxicity and action mechanisms of silver nanoparticles against the mycotoxin-producing fungus Fusarium graminearum. J. Adv. Res.38, 1–12 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Roguska, A. et al. Metal TiO 2 Nanotube Layers for the Treatment of Dental Implant Infections. ACS Appl. Mater. Interfaces. 10, 17089–17099 (2018). [DOI] [PubMed] [Google Scholar]
- 53.Czajka, K. M. et al. Molecular Mechanisms Associated with Antifungal Resistance in Pathogenic Candida Species. Cells12, 2655 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
The datasets analysed during the current study are available from the corresponding author on reasonable request.








